Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma

DSpace Repository

Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma

Author: Mai, Elias K.; Hielscher, Thomas; Bertsch, Uta; Schlenzka, Jana; Salwender, Hans J.; Munder, Markus; Gerecke, Christian; Duehrsen, Ulrich; Brossart, Peter; Neben, Kai; Hillengass, Jens; Raab, Marc S.; Merz, Maximilian; Baertsch, Marc-Andrea; Jauch, Anna; Hose, Dirk; Martin, Hans; Lindemann, Hans-Walter; Blau, Igor W.; Scheid, Christof; Weisel, Katja C.; Goldschmidt, Hartmut
Tübinger Autor(en):
Weisel, Katja
Published in: Leukemia (2019), Bd. 33, H. 1, S. 258-261
Verlagsangabe: Nature Publishing Group
Language: English
Full text: http://dx.doi.org/10.1038/s41375-018-0195-9
ISSN: 1476-5551
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)